22:52 , Jul 20, 2018 |  BioCentury  |  Finance

JOBS Jolt 3.0?

The latest iteration of the JOBS Act could make it easier for biotechs to go public -- and raise more money more quickly -- but that doesn’t necessarily mean the quality of the IPO queue...
00:47 , Jul 18, 2018 |  BC Extra  |  Politics & Policy

House passes ‘JOBS Act 3.0’

The House of Representatives passed legislation 406-4 on Tuesday that could make it easier for small biotechs to go public. The JOBS and Investor Confidence Act of 2018 is a collection of 32 bills, including H.R....
01:01 , Mar 30, 2017 |  BC Week In Review  |  Financial News

Imprimis completes registered public offering

Drug delivery company and compounding pharmacy Imprimis Pharmaceuticals Inc. (NASDAQ:IMMY) raised $3.1 million through the sale of 1.3 million shares at $2.40 in a registered direct offering on March 22 to two accredited investors. National...
19:50 , Mar 15, 2017 |  BC Week In Review  |  Financial News

Gemphire completes private placement

On March 10, dyslipidemia company Gemphire Therapeutics Inc. (NASDAQ:GEMP) raised $12.5 million through the sale of 1.3 million units at $9.47 in a private placement with accredited investors. Each unit comprises a share and a...
12:50 , Mar 9, 2017 |  BC Week In Review  |  Financial News

XBiotech completes direct public offering

Antibody company XBiotech Inc. (NASDAQ:XBIT) raised $31.9 million through the sale of 2.5 million shares at $13 in a registered direct offering with accredited investors on March 3. XBiotech Inc. (NASDAQ:XBIT), Austin, Texas   ...
19:02 , Feb 24, 2017 |  BC Week In Review  |  Financial News

Arch Therapeutics completes direct public offering

On Feb. 21, hemostasis company Arch Therapeutics Inc. (OTCQB:ARTH) raised $6.1 million through the sale of 10.2 million units at $0.60 in a registered direct offering with six accredited investors. Each unit comprises a share...
20:38 , Jan 6, 2017 |  BC Week In Review  |  Financial News

Oncobiologics completes private placement of senior notes and warrants

Oncobiologics raised $8.4 million through the sale of 5% senior secured promissory notes in an initial close of a planned $10 million private placement with accredited investors. The notes mature on Dec. 22. Investors also...
01:22 , Dec 30, 2016 |  BC Week In Review  |  Financial News

Rasna Therapeutics completes private placement

Rasna raised $2 million through the sale of 3.4 million shares at $0.60 in a private placement to accredited investors. Rasna Therapeutics Inc. (OTCQB:RASP), New York, N.Y.  ...
17:23 , Dec 22, 2016 |  BC Week In Review  |  Financial News

Imprimis completes private placement

Imprimis raised $9.8 million through the sale of 5.1 million units at $1.92 in a private placement with accredited investors and company directors and management. Each unit comprises a share and a three-year warrant to...
22:58 , Dec 14, 2016 |  BC Week In Review  |  Financial News

Inspyr completes private placement of convertible preferred stock and warrants

Inspyr raised $1 million through the sale of about 1,000 shares of series B convertible preferred stock at $1,000 in a private placement to institutional and accredited investors. The shares initially convert at $0.75. Investors...